Literature DB >> 330399

Gastrointestinal antibody responses in axenic mice to topically administered Escherichia coli.

J L Ebersole, J A Molinari.   

Abstract

Immunoglobulin levels were determined in gastrointestinal secretions of both conventional and axenic mice, as was the stability of the immunoglobulin classes in these secretions. Axenic animals were then administered nonviable Escherichia coli O111:B4 by topical application into the oral cavity. Immunoglobulin (Ig) A, IgG1, AND IgG2 were detected in the gastrointestinal secretions, with an apparent gradation in stability (IgA greater than IgG1 greater than IgG2) under the conditions investigated. Specific antibodies (IgA and IgG) to both the somatic and the flagellar antigens of E. coli were demonstrated. The time course of the responses to the polysaccharide and protein antigens suggested that a secondary response to lipolysaccharide was being observed in the secretions. Examination of the autoclaved diet fed to the germfree animals indicated the presence of antigenically intact polysaccharide materials (i.e., lipopolysaccharides), whereas antigenic bacterial proteins were uniformly undetectable. Therefore, endotoxin in the diet was apparently causing a primary type of sensitization in the mice, whereas the active oral immunization regimen induced a secondary antibacterial response in the secretions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330399      PMCID: PMC421055          DOI: 10.1128/iai.16.3.938-946.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  The relative proportions of IgG-, IgAand IgM-containing cells in rabbit tissues during experimental trichinosis.

Authors:  R B Crandall; J J Cebra; C A Crandall
Journal:  Immunology       Date:  1967-02       Impact factor: 7.397

2.  Dietary stimulation of immune mechanisms.

Authors:  B S Wostmann; J R Pleasants; P Bealmear
Journal:  Fed Proc       Date:  1971 Nov-Dec

3.  Antibody activity in human duodenal fluid.

Authors:  J P Girard; A de Kalbermatten
Journal:  Eur J Clin Invest       Date:  1970-11       Impact factor: 4.686

4.  Protection against enteric bacterial infection by secretory IgA antibodies.

Authors:  E S Fubara; R Freter
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

5.  Immunoglobulins in human small intestinal fluid.

Authors:  A G Plaut; P Keonil
Journal:  Gastroenterology       Date:  1969-03       Impact factor: 22.682

6.  The normal microbial flora as a major stimulus for proliferation of plasma cells synthesizing IgA in the gut. The germ-free intestinal tract.

Authors:  P A Crabbé; H Bazin; H Eyssen; J F Heremans
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

7.  Sequential appearance of salivary antibodies after oral immunization of axenic mice.

Authors:  J L Ebersole; J A Molinari; D Platt
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

8.  Identification of secretory IgA, free secretory piece and serum IgA in the ovine and caprine species.

Authors:  J J Pahud; J P Mach
Journal:  Immunochemistry       Date:  1970-08

9.  The immunoglobulins of the dog. II. The immunoglobulins of canine secretions.

Authors:  J P Vaerman; J F Heremans
Journal:  Immunochemistry       Date:  1969-11

10.  Specificity of secretory antibodies to bacterial immunogens.

Authors:  J L Ebersole; J A Molinari
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

View more
  3 in total

1.  The effect of neonatal thymectomy on the level of salivary and serum immunoglobulins in rats.

Authors:  J L Ebersole; M A Taubman; D J Smith
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

2.  The induction of salivary antibodies by topical sensitization with particulate and soluble bacterial immunogens.

Authors:  J L Ebersole; J A Molinari
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

3.  Flagella allow uropathogenic Escherichia coli ascension into murine kidneys.

Authors:  William R Schwan
Journal:  Int J Med Microbiol       Date:  2007-09-20       Impact factor: 3.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.